BRISTOL MYERS SQUIBB CO (BMY)

Latest Insider Confidence Score

2026Q1

47.5
Bearish

Company insider confidence (by quarter)

2019Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Celgene Corp /de/ 10% Owner 7,047,489 Jul 13, 2020
Bristol Myers Squibb Co 10% Owner 7,047,489 Jul 13, 2020
Caforio Giovanni Chair 142,904 Mar 12, 2024
Boerner Christopher S. CEO 125,439 Nov 4, 2025
Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. 83,513.49 Apr 29, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 27, 2026 Mar 3, 2026 Hickey Benjamin President Sell 22.5 -1,672 -9.11% ✗ $104.3K
Feb 1, 2026 Feb 3, 2026 Meyers Gregory Scott EVP, Chief Digital & Tech Off. Sell 26.3 -833 -3.74% ✗ $45.9K
Feb 1, 2026 Feb 3, 2026 Hickey Benjamin President Sell 22.5 -3,810 -20.19% ✗ $209.7K
Feb 1, 2026 Feb 3, 2026 YALE PHYLLIS R Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2026 Feb 3, 2026 Vousden Karen H Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2026 Feb 3, 2026 Samuels Theodore R. II Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2026 Feb 3, 2026 Rice Derica W Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2026 Feb 3, 2026 Price Paula A Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2026 Feb 3, 2026 McMullen Michael R. Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2026 Feb 3, 2026 Hidalgo Medina Manuel Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2026 Feb 3, 2026 Haller Julia A Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2026 Feb 3, 2026 Bhatt Deepak Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2026 Feb 3, 2026 Arduini Peter J Director Neutral 52.5 - 0.00% ✗ -
Dec 31, 2025 Jan 5, 2026 YALE PHYLLIS R Director Neutral 52.5 - 0.00% ✗ -
Dec 31, 2025 Jan 5, 2026 Samuels Theodore R. II Director Neutral 52.5 - 0.00% ✗ -
Dec 31, 2025 Jan 5, 2026 Rice Derica W Director Neutral 52.5 - 0.00% ✗ -
Dec 31, 2025 Jan 5, 2026 McMullen Michael R. Director Neutral 52.5 - 0.00% ✗ -
Dec 31, 2025 Jan 5, 2026 Arduini Peter J Director Neutral 52.5 - 0.00% ✗ -
Nov 3, 2025 Nov 4, 2025 Lenkowsky Adam EVP, Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Nov 1, 2025 Nov 4, 2025 BOERNER CHRISTOPHER S. CEO Sell 22.5 -1,782 -1.39% ✗ $57K
Nov 1, 2025 Nov 4, 2025 Meyers Gregory Scott EVP, Chief Digital & Tech Off. Sell 22.5 -2,665 -11.91% ✗ $122.8K
Nov 1, 2025 Nov 4, 2025 Shanahan Karin EVP, Chief Supply Chain & Ops Sell 22.5 -3,213 -15.04% ✗ $148K
Oct 2, 2025 Oct 6, 2025 Gallman Cari EVP, General Counsel Sell 22.5 -2,332 -17.41% ✗ $106.6K
Sep 30, 2025 Oct 2, 2025 YALE PHYLLIS R Director Neutral 52.5 - 0.00% ✗ -
Sep 30, 2025 Oct 2, 2025 Samuels Theodore R. II Director Neutral 52.5 - 0.00% ✗ -
Sep 30, 2025 Oct 2, 2025 Rice Derica W Director Neutral 52.5 - 0.00% ✗ -
Sep 30, 2025 Oct 2, 2025 McMullen Michael R. Director Neutral 52.5 - 0.00% ✗ -
Sep 30, 2025 Oct 2, 2025 Arduini Peter J Director Neutral 52.5 - 0.00% ✗ -
Sep 2, 2025 Sep 3, 2025 Elkins David V CFO Sell 5.0 -56,000 -25.04% ✓ $2.7M
Sep 1, 2025 Sep 3, 2025 Short Bartie Wendy EVP, Corporate Affairs Sell 26.3 -632 -10.03% ✗ $29.8K
Aug 1, 2025 Aug 5, 2025 Massacesi Cristian EVP,Chief Med Offr,Head of Dev Neutral 52.5 - 0.00% ✗ -
Aug 5, 2025 Massacesi Cristian EVP,Chief Med Offr,Head of Dev Neutral 52.5 - 0.00% ✗ -
Aug 1, 2025 Aug 5, 2025 Gallman Cari EVP, General Counsel Sell 26.3 -543 -5.79% ✗ $24K
Aug 2, 2025 Aug 5, 2025 Short Bartie Wendy EVP, Corporate Affairs Sell 26.3 -378 -6.94% ✗ $16.7K
Jul 1, 2025 Jul 2, 2025 Shibutani Hiroshi Chris EVP, Chief Strategy Officer Neutral 52.5 - 0.00% ✗ -
Jun 30, 2025 Jul 1, 2025 Arduini Peter J Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2025 Jul 1, 2025 McMullen Michael R. Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2025 Jul 1, 2025 Rice Derica W Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2025 Jul 1, 2025 Samuels Theodore R. II Director Neutral 52.5 - 0.00% ✗ -
Jun 30, 2025 Jul 1, 2025 YALE PHYLLIS R Director Neutral 52.5 - 0.00% ✗ -
Jun 16, 2025 Shibutani Hiroshi Chris EVP, Chief Strategy Officer Neutral 52.5 - 0.00% ✗ -
Jun 13, 2025 Jun 16, 2025 BOERNER CHRISTOPHER S. CEO Neutral 52.5 - 0.00% ✗ -
Jun 3, 2025 Jun 4, 2025 Short Bartie Wendy EVP, Corporate Affairs Sell 22.5 -3,334 -41.47% ✗ $160.3K
Jun 4, 2025 Short Bartie Wendy EVP, Corporate Affairs Neutral 52.5 - 0.00% ✗ -
Jun 3, 2025 Jun 4, 2025 BOERNER CHRISTOPHER S. CEO Neutral 52.5 - 0.00% ✗ -
May 9, 2025 May 13, 2025 Hickey Benjamin President Sell 27.5 -97 -1.10% ✗ $3.7K
May 1, 2025 May 5, 2025 Lenkowsky Adam EVP, Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Apr 25, 2025 Apr 29, 2025 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Buy 90.0 +4,250 5.36% ✗ $202.2K
Apr 1, 2025 Apr 3, 2025 Shanahan Karin EVP, Glob. Prod. Dev. & Supply Sell 22.5 -1,692 -10.09% ✗ $100.8K
Mar 31, 2025 Apr 1, 2025 YALE PHYLLIS R Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 1, 2025 Samuels Theodore R. II Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 1, 2025 Rice Derica W Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 1, 2025 McMullen Michael R. Director Neutral 52.5 - 0.00% ✗ -
Mar 31, 2025 Apr 1, 2025 Arduini Peter J Director Neutral 52.5 - 0.00% ✗ -
Mar 10, 2025 Mar 12, 2025 Plenge Robert M EVP, Chief Research Officer Sell 22.5 -6,731 -5.61% ✗ $227.8K
Mar 10, 2025 Mar 12, 2025 Meyers Gregory Scott EVP, Chief Digital & Tech Off. Sell 20.0 -14,044 -15.70% ✗ $423.5K
Mar 10, 2025 Mar 12, 2025 Shanahan Karin EVP, Glob. Prod. Dev. & Supply Sell 20.0 -13,576 -18.35% ✗ $452.7K
Mar 10, 2025 Mar 12, 2025 Lenkowsky Adam EVP, Chief Commercial Officer Sell 20.0 -10,895 -11.08% ✗ $382.8K
Mar 10, 2025 Mar 12, 2025 Poole Ahn Amanda EVP, Chief People Officer Sell 22.5 -4,392 -11.94% ✗ $143.4K
Mar 10, 2025 Mar 12, 2025 LEUNG SANDRA EVP, General Counsel Sell 17.5 -31,807 -1.06% ✗ $1.1M
Mar 10, 2025 Mar 12, 2025 Hoch Lynelle President Sell 22.5 -4,461 -14.49% ✗ $141.9K
Mar 10, 2025 Mar 12, 2025 Holzer Phil M SVP and Controller Sell 22.5 -3,933 -3.53% ✗ $114.9K
Mar 10, 2025 Mar 12, 2025 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Sell 17.5 -28,767 -4.70% ✗ $1M
Mar 10, 2025 Mar 12, 2025 Hickey Benjamin President Neutral 52.5 - 0.00% ✗ -
Mar 10, 2025 Mar 12, 2025 Gallman Cari EVP, Corporate Affairs Sell 22.5 -4,285 -7.51% ✗ $122.4K
Mar 10, 2025 Mar 12, 2025 Elkins David V CFO Sell 17.5 -41,106 -2.38% ✗ $1.3M
Mar 10, 2025 Mar 12, 2025 BOERNER CHRISTOPHER S. CEO Sell 17.5 -39,221 -4.02% ✗ $1.4M
Mar 1, 2025 Mar 4, 2025 Hickey Benjamin President Sell 22.5 -1,630 -15.51% ✗ $97.2K
Feb 20, 2025 Feb 21, 2025 BOERNER CHRISTOPHER S. CEO Buy 82.5 +2,000 1.95% ✗ $110.1K
Feb 14, 2025 Feb 19, 2025 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Buy 87.5 +1,823 2.94% ✗ $100K
Feb 1, 2025 Feb 4, 2025 YALE PHYLLIS R Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2025 Feb 4, 2025 Vousden Karen H Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2025 Feb 4, 2025 Samuels Theodore R. II Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2025 Feb 4, 2025 Rice Derica W Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2025 Feb 4, 2025 Price Paula A Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2025 Feb 4, 2025 McMullen Michael R. Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2025 Feb 4, 2025 Hidalgo Medina Manuel Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2025 Feb 4, 2025 Haller Julia A Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2025 Feb 4, 2025 Bhatt Deepak Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2025 Feb 4, 2025 Arduini Peter J Director Neutral 52.5 - 0.00% ✗ -
Feb 1, 2025 Feb 4, 2025 Hickey Benjamin President Sell 22.5 -3,725 -34.02% ✗ $219.6K
Feb 1, 2025 Feb 4, 2025 Meyers Gregory Scott EVP, Chief Digital & Tech Off. Sell 26.3 -833 -10.64% ✗ $49.1K
Dec 31, 2024 Jan 2, 2025 YALE PHYLLIS R Director Neutral 52.5 - 0.00% ✗ -
Dec 31, 2024 Jan 2, 2025 Samuels Theodore R. II Director Neutral 52.5 - 0.00% ✗ -
Dec 31, 2024 Jan 2, 2025 Rice Derica W Director Neutral 52.5 - 0.00% ✗ -
Dec 31, 2024 Jan 2, 2025 McMullen Michael R. Director Neutral 52.5 - 0.00% ✗ -
Dec 31, 2024 Jan 2, 2025 Arduini Peter J Director Neutral 52.5 - 0.00% ✗ -
Nov 4, 2024 Nov 5, 2024 Holzer Phil M SVP and Controller Sell 26.3 -700 -5.62% ✗ $38.9K
Nov 1, 2024 Nov 5, 2024 Shanahan Karin EVP, Glob. Prod. Dev. & Supply Neutral 52.5 - 0.00% ✗ -
Nov 1, 2024 Nov 5, 2024 Meyers Gregory Scott EVP, Chief Digital & Tech Off. Neutral 52.5 - 0.00% ✗ -
Nov 1, 2024 Nov 5, 2024 BOERNER CHRISTOPHER S. CEO Sell 22.5 -1,543 -1.48% ✗ $80.8K
Nov 1, 2024 Nov 5, 2024 Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. Buy 87.5 +1,830 3.04% ✗ $100.1K
Oct 2, 2024 Oct 3, 2024 Gallman Cari EVP, Corporate Affairs Sell 22.5 -1,648 -24.72% ✗ $88.6K
Sep 30, 2024 Oct 2, 2024 YALE PHYLLIS R Director Neutral 52.5 - 0.00% ✗ -
Sep 30, 2024 Oct 2, 2024 Samuels Theodore R. II Director Neutral 52.5 - 0.00% ✗ -
Sep 30, 2024 Oct 2, 2024 Rice Derica W Director Neutral 52.5 - 0.00% ✗ -
Sep 30, 2024 Oct 2, 2024 McMullen Michael R. Director Neutral 52.5 - 0.00% ✗ -
Sep 30, 2024 Oct 2, 2024 Bhatt Deepak Director Neutral 52.5 - 0.00% ✗ -
Sep 30, 2024 Oct 2, 2024 Arduini Peter J Director Neutral 52.5 - 0.00% ✗ -
Aug 1, 2024 Aug 5, 2024 Gallman Cari EVP, Corporate Affairs Sell 26.3 -384 -15.40% ✗ $18.5K